1.14.19.30: acyl-lipid (8-3)-desaturase
This is an abbreviated version!
For detailed information about acyl-lipid (8-3)-desaturase, go to the full flat file.
Word Map on EC 1.14.19.30
-
1.14.19.30
-
arachidonic
-
polyunsaturated
-
linoleic
-
desaturation
-
phospholipid
-
desaturases
-
pufas
-
delta-6
-
docosahexaenoic
-
eicosapentaenoic
-
dihomo-gamma-linolenic
-
delta6-desaturase
-
elongase
-
monounsaturated
-
alpha-linolenic
-
gamma-linolenic
-
stearoyl-coa
-
mortierella
-
omega-6
-
alpina
-
8-hydroxyoctanoic
-
lc-pufas
-
sesamin
-
eicosatrienoic
-
medicine
-
agriculture
-
diagnostics
- 1.14.19.30
-
arachidonic
-
polyunsaturated
-
linoleic
-
desaturation
- phospholipid
-
desaturases
-
pufas
-
delta-6
-
docosahexaenoic
-
eicosapentaenoic
-
dihomo-gamma-linolenic
- delta6-desaturase
- elongase
-
monounsaturated
-
alpha-linolenic
-
gamma-linolenic
- stearoyl-coa
-
mortierella
-
omega-6
- alpina
-
8-hydroxyoctanoic
-
lc-pufas
- sesamin
-
eicosatrienoic
- medicine
- agriculture
- diagnostics
Reaction
+ 2 ferrocytochrome b5 + + 2 H+ = + 2 ferricytochrome b5 + 2 H2O
Synonyms
acyl-lipid 5-desaturase, AL21, C20 DELTA5cis-desaturase, D5b, D5D, D5des, delta 5 desaturase, DELTA 5 fatty acid desaturase, delta-5 desaturase, DELTA-5-desaturase, DELTA5 desaturase, DELTA5 fatty acid desaturase, DELTA5-Des, DELTA5-desaturase, DELTA5-fatty acid desaturase, DELTA5-fatty-acid desaturase, DES5, desat7, FadA, FadB, FADS1, fads2b, FAT-4, fatty acid desaturase, PPDES5, PsD5Des
ECTree
Advanced search results
Inhibitors
Inhibitors on EC 1.14.19.30 - acyl-lipid (8-3)-desaturase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
2-(2,2,3,3,3-pentafluoropropoxy)-3-[4-(2,2,2-trifluoroethoxy)phenyl]-5,7-dihydro-3H-pyrrolo[2,3-d]pyrimidine-4,6-dione
-
-
5-[(4S,5S)-5-(4-fluorophenyl)-4-methyl-2-oxo-1,3-oxazolidin-3-yl]benzene-1,3-dicarbonitrile
CP-24879
the combined DELTA5 desaturase/DELTA6 desaturase inhibitor significantly reduces intracellular lipid accumulation and inflammatory injury in hepatocytes
derivative with improved metabolic stability
3-[(4S,5S)-5-(4-fluorophenyl)-4-methyl-2-oxo-1,3-oxazolidin-3-yl]benzonitrile
derivative with improved metabolic stability
3-[(4S,5S)-5-(4-fluorophenyl)-4-methyl-2-oxo-1,3-oxazolidin-3-yl]benzonitrile
-
derivative with improved metabolic stability
-
5-[(4S,5S)-5-(4-fluorophenyl)-4-methyl-2-oxo-1,3-oxazolidin-3-yl]benzene-1,3-dicarbonitrile
inhibitor endowed with excellent DELTA5 desaturase binding affinity, cellular activity, and high oral bioavailability in a mouse. It exhibits robust in vivo hepatic arachidonic acid/dihomo-gamma-linolenic acid ratio reduction (a target engagement marker) in an atherosclerosis mouse model
5-[(4S,5S)-5-(4-fluorophenyl)-4-methyl-2-oxo-1,3-oxazolidin-3-yl]benzene-1,3-dicarbonitrile
-
-